Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BB2603 topical treatment for distal subungual onychomycosis of the toenail
2019-002098-68Phase 2Completed
- Sponsor
- Blueberry Therapeutics
- Start
- Aug 2019
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in onychomycosis comparing BB2603 topical treatment with Vehicle control (2 arms). Primary endpoints: Early clinical response and Early mycological response. Started Aug 2019; status: completed.
02
Drugs
BB2603
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2019-002098-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002098-68.